Your session is about to expire
← Back to Search
HIV Self-testing for Human Immunodeficiency Virus Infection
N/A
Waitlist Available
Led By Carmen Logie, PhD
Research Sponsored by University of Toronto
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up time 1 (month 0), time 2 (month 3)
Awards & highlights
Study Summary
This trial is testing whether or not a comic book can help improve linkage to care with HIVST for adolescents and young people in Bidi Bidi who have been displaced or are refugees.
Eligible Conditions
- Human Immunodeficiency Virus Infection
- Knowledge, Attitudes, and Practices (KAP)
- HIV/AIDS
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ time 1 (month 0), time 2 (month 3)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~time 1 (month 0), time 2 (month 3)
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Changes in HIV testing frequency
HIV status knowledge
Secondary outcome measures
Adolescent sexual and reproductive health stigma
Change in HIV knowledge
Change in HIV-related stigma
+7 moreTrial Design
4Treatment groups
Experimental Treatment
Active Control
Group I: HIV self-testing + educational comic bookExperimental Treatment2 Interventions
At the first visit participants will receive a HIVST kit and a detailed description of how to use the HIVST kits, pictorial and written guide for HIVST kits, in addition to contact information for confirmatory testing and linkage to care at local clinics. Participants will also receive an educational comic book focused on HIV testing information and decision making that was developed with qualitative data collected from an earlier study phase. PNs will meet with small groups of participants to read through and discuss the comic book together.
Group II: Standard of CareActive Control1 Intervention
PNs will provide information about HIV testing, care and support services at local clinics.
Group III: HIV self-testingActive Control1 Intervention
At the first visit participants will receive a HIVST kit and a detailed description of how to use the HIVST kits, pictorial and written guide for HIVST kits, in addition to contact information for confirmatory testing and linkage to care at local clinics.
Group IV: Educational comic bookActive Control1 Intervention
Participants will receive an educational comic book focused on HIV testing information and decision making that was developed with qualitative data collected from an earlier study phase. PNs will meet with small groups of participants to read through and discuss the comic book together.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
HIV Self-testing
2016
N/A
~200
Find a Location
Who is running the clinical trial?
University of TorontoLead Sponsor
689 Previous Clinical Trials
1,018,523 Total Patients Enrolled
ViiV HealthcareIndustry Sponsor
359 Previous Clinical Trials
468,423 Total Patients Enrolled
Carmen Logie, PhDPrincipal InvestigatorUniversity of Toronto
5 Previous Clinical Trials
1,133 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Share this study with friends
Copy Link
Messenger